Showing results (1691-1700 of 2,938) with videos related to
Sort By:
Pageof 294
Cancer Investigation|January 1, 1988
Reactivity of the monoclonal antibody B72.3 with fetal antigen: correlation with expression of TAG-72 in human carcinomasD Stanick, A Schuss, Y Mishriki, et al.Cancer Investigation|November 27, 2019
Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell CarcinomaSongbing Qin, Xiang Long, Qi Zhao, et al.Cancer Investigation|January 12, 2019
Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of ResearchEmaad Khansur, Ashish H Shah, Kyle Lacy, et al.Cancer Investigation|December 24, 2019
Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells in Vitro: Repressive Effect of Extracellular RegucalcinMasayoshi Yamaguchi, Tomiyasu MurataCancer Investigation|July 6, 2016
A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal TumorsJohanna C Bendell, Todd M Bauer, Ruth Lamar, et al.Cancer Investigation|March 6, 2018
Review of Polymorphism of the Calcium-Sensing Receptor Gene and Breast Cancer RiskLarysse Maira Campos-Verdes, Danylo Rafhael Costa-Silva, João Paulo da Silva-Sampaio, et al.Cancer Investigation|March 6, 2018
Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISHAbdelbaset Buhmeida, Mourad Assidi, Jaudah Al-Maghrabi, et al.Cancer Investigation|December 16, 2017
Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal CancerShahram Agah, Abolfazl Akbari, Atefeh Talebi, et al.Cancer Investigation|January 19, 2023
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell LymphomaChenyu Lin, Ahmed Galal, David Rizzieri, et al.Cancer Investigation|April 12, 2001
Determinants of place of death for terminal cancer patientsS T Tang, R McCorklePageof 294